Ida E. Herdlevaer
Bergen, Norway
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
A cerebellar degeneration-related protein 2-like cell-based assay for anti-Yo detection in patients with paraneoplastic cerebellar degeneration.
Journal: European journal of neurology
Published: November 09, 2022
GUBS: Graph-Based Unsupervised Brain Segmentation in MRI Images.
Journal: Journal of imaging
Published: August 17, 2022
Editorial: Autoimmunity and the Brain: Paraneoplastic Neurological Injury and Beyond.
Journal: Frontiers in neurology
Published: March 20, 2022
Expression of cerebellar degeneration-related proteins CDR2 and CDR2L in human and rat brain tissue.
Expression of cerebellar degeneration-related proteins CDR2 and CDR2L in human and rat brain tissue.
Journal: Journal of neuroimmunology
Published: March 21, 2021
Paraneoplastic Cerebellar Degeneration: The Importance of Including CDR2L as a Diagnostic Marker.
Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: October 21, 2020
Localization of CDR2L and CDR2 in paraneoplastic cerebellar degeneration.
Journal: Annals of clinical and translational neurology
Published: June 26, 2020
Reply to "CDR2 and CDR2L Yo Antigens in Paraneoplastic Cerebellar Degeneration".
Journal: Annals of neurology
Published: May 14, 2020
CDR2L Is the Major Yo Antibody Target in Paraneoplastic Cerebellar Degeneration.
Journal: Annals of neurology
Published: November 26, 2018
Childbirth or termination of pregnancy: does paid employment matter? A population study of women in reproductive age in Norway.
Journal: Acta obstetricia et gynecologica Scandinavica
Published: August 23, 2015
Showing 1-11 of 11
Last Updated: 09/26/2026